20 AIDX
NASDAQ AIDX
$0.51 +0.01 (+1.06%)
At close: Aug 20, 2026 · 2:07 PM UTC

20 (AIDX) Net Income (2025 - 2026)

20's (AIDX) quarterly Net Income came in at -$2.1 million in Q1 2026, down 174.43% YoY from $2.8 million in Q1 2025, and down 174.43% on a QoQ basis from -$764462.0 in Q1 2025.

20 (AIDX) Net Income (2025 - 2026) Analysis & Trends

20 (AIDX) has 2 years of Net Income data on file, last reported at -$2.1 million in Q1 2026.

  • Quarterly Net Income fell 174.43% year-over-year to -$2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.9 million (changed N/A YoY) and the FY2025 annual result came in at -$3.8 million, up 30.86% from the prior year.
  • Net Income slipped to -$2.1 million in Q1 2026, from -$764462.0 in the prior quarter.
  • In the past five years, Net Income ranged from a high of -$764462.0 in Q1 2025 to a low of -$2.1 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 199.49 Bn 193.88 Bn 7.27 Bn 928.00 Mn
2 Stryker 127.80 Bn 124.32 Bn 4.50 Bn 1.28 Bn
3 Medtronic 118.98 Bn 109.76 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 73.58 Bn 73.04 Bn 3.85 Bn 905.00 Mn
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn 241.40 Mn
6 Dexcom 34.34 Bn 32.39 Bn 830.00 Mn 249.10 Mn
7 GE HealthCare Technologies 33.76 Bn 31.66 Bn 2.18 Bn 574.00 Mn
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn 618.38 Mn
9 Steris 23.07 Bn 22.59 Bn 684.20 Mn 201.00 Mn
10 20 5.55 Mn 1.00 Mn 304,727.00 -1.50 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.10 Mn
Mar 31, 2025 -764,462.00